BAKER BROS. ADVISORS LP Insider Trading Activity

Average Profitability
12.01%
Insider Buys Quantity
121
Insider Buys Sum
$2.27B
Insider Sells Quantity
20
Insider Sells Sum
$88.3M

Insider Activity of BAKER BROS. ADVISORS LP

According to the SEC Form 4 filings, BAKER BROS. ADVISORS LP, being in a position of

  1. 10 percent owner at Celcuity Inc.,
    оver the last 12 months, has bought 170100 shares for $9.57M, and sold 0 shares,
    over all time since 2025-09-08, has bought 170100 shares for $9.57M, and sold 0 shares.
  2. 10 percent owner at Entrada Therapeutics, Inc.,
    оver the last 12 months, has bought 206911 share for $1.61M, and sold 0 shares,
    over all time since 2022-05-16, has bought 368311 share for $2.59M, and sold 0 shares.
  3. Former 10% owner at KALA BIO, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 730408 shares for $1.06M,
    over all time since 2024-12-30, has bought 310559 shares for $2M, and sold 730408 shares for $1.06M.
  4. at Kodiak Sciences Inc.,
    оver the last 12 months, has bought 2608696 shares for $60M, and sold 0 shares,
    over all time since 2018-10-09, has bought 16695694 shares for $672.86M, and sold 0 shares.
  5. at Kymera Therapeutics, Inc.,
    оver the last 12 months, has bought 2661313 shares for $201.34M, and sold 0 shares,
    over all time since 2024-08-20, has bought 2661314 shares for $201.34M, and sold 0 shares.
  6. director at Madrigal Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 165683 shares for $61.92M, and sold 0 shares,
    over all time since 2023-11-13, has bought 590368 shares for $139.67M, and sold 0 shares.

Biography of BAKER BROS. ADVISORS LP

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$334,448,7021083
Sells
$1,056,722217

Comparison of Insiders on Amount of Buys and Sells

2026-04-20SaleAehr Test Systems
AEHR
Exec VP of Sales & Mktg.
2,431
0.0083%
$90.00$218,790-6.82%
2026-04-20SaleAehr Test Systems
AEHR
Director
7,500
0.025%
$88.09$660,675-4.8%
2026-04-20SaleASE Technology Holding Co., Ltd.
ASX
director
9,000
0.0066%
$461.50$4.15M-93.81%
2026-04-20PurchaseAMREP Corporation
AXR
10 percent owner
1,519
0.0286%
$27.25$41,393
2026-04-20SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Executive Officer
15,000
0.0269%
$23.61$354,146
2026-04-20PurchaseCity Holding Company
CHCO
director
103
0.0007%
$126.36$13,015+0.69%
2026-04-20PurchaseCity Holding Company
CHCO
director
103
0.0007%
$126.36$13,015+0.69%
2026-04-20PurchaseCity Holding Company
CHCO
director
119
0.0008%
$126.36$15,037+0.69%
2026-04-20PurchaseCity Holding Company
CHCO
director
133
0.0009%
$126.36$16,806+0.69%
2026-04-20PurchaseDolphin Entertainment, Inc.
DLPN
Chief Executive Officer
3,200
0.0257%
$1.52$4,877+0.39%
2026-04-20SaleEtsy, Inc.
ETSY
Executive Chair of the Board
30,369
0.0318%
$64.00$1.94M-3.28%
2026-04-20PurchaseGloo Holdings, Inc.
GLOO
President and CEO
2,800
0.0123%
$7.98$22,344
2026-04-20SaleGuidewire Software, Inc.
GWRE
Chief Executive Officer
1,200
0.0014%
$139.75$167,700
2026-04-20PurchaseInsight Molecular Diagnostics Inc.
IMDX
10 percent owner
40,690
0.1533%
$3.88$157,967
2026-04-20SaleMorgan Stanley
MS
Chief Legal/Admin Officer
11,118
0.0007%
$190.75$2.12M-1%
2026-04-20SaleUWM Holdings Corporation
UWMC
President and CEO
1M
0.0663%
$3.94$3.94M-0.51%
2026-04-20SaleWestamerica Bancorporation
WABC
SVP/Banking Division Manager
759
0.0031%
$53.83$40,860
2026-04-17SaleAehr Test Systems
AEHR
Director
25,000
0.0836%
$85.00$2.13M-1.34%
2026-04-17SaleAehr Test Systems
AEHR
Director
7,500
0.0242%
$82.00$615,000+2.27%
2026-04-17SaleAfya Limited
AFYA
Controller
3,325
0.0037%
$15.90$52,868-0.25%
Total: 844594
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.